Skip to main content
Clinical and Translational Science logoLink to Clinical and Translational Science
. 2014 Nov 12;8(4):347–350. doi: 10.1111/cts.12237

Worldwide Distribution of Four SNPs in X‐Ray and Repair and Cross‐Complementing Group 1 (XRCC1)

Haruo Takeshita 1,2, Junko Fujihara 1,, Toshihiro Yasuda 3, Kaori Kimura‐Kataoka 1
PMCID: PMC5351033  PMID: 25387884

Abstract

Purpose

X‐ray repair cross‐complementing group 1 (XRCC1) repairs single‐strand breaks in DNA. Several reports have shown the association of single nucleotide polymorphisms (SNPs) (Arg194Trp, Pro206Pro, Arg280His, Arg399Gln) in XRCC1 to diseases. Limited population data are available regarding SNPs in XRCC1, especially in African populations. In this study, genotype distributions of four SNPs in worldwide populations were examined and compared with those reported previously.

Materials and Methods

Four SNPs (Arg194Trp, Pro206Pro, Arg280His, Arg399Gln) in XRCC1 from genomic DNA samples of 10 populations were evaluated by using polymerase chain reaction followed by restriction fragment length polymorphism analysis.

Results

The frequency of the minor allele corresponding to the Trp allele of XRCC1Arg194Trp was higher in Asian populations than in African and Caucasian populations. As for XRCC1Pro206Pro, Africans showed higher minor allele frequencies than did Asian populations, except for Tamils and Sinhalese. XRCC1 Arg280His frequencies were similar among Africans and Caucasians but differed among Asian populations. Similarly, lower mutant XRCC1 Arg399Gln frequencies were observed in Africans.

Conclusions

This study is the first to show the existence of a certain genetic heterogeneity in the worldwide distribution of four SNPs in XRCC1.

Keywords: x‐ray repair cross‐complementing group 1 (XRCC1), DNA repair, ethnic differences, single nucleotide polymorphisms (SNP), base excision repair (BER)

Introduction

There are two main DNA repair pathways: base excision repair (BER) and nucleotide excision repair.1, 2 Among genes in the BER pathway, human 8‐oxoguanine DNA glycosylase (hOGG1), apurinic/apyrimidinic endonuclease (APE1), and x‐ray repair cross‐complementing group 1 (XRCC1) have been especially well studied. 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG) is a byproduct of ROS damage to DNA: 8‐OHdG genes are repaired by hOGG1 in combination with APE1.3 XRCC1, a multidomain protein, repairs single‐strand breaks in DNA that result from either the BER process itself or damage to deoxyribose.4, 5

Single nucleotide polymorphisms (SNPs) in the genes involved in DNA repair pathways could influence susceptibility to oxidative damage. Variants in three genes, hOGG1 Ser326Cys (rs1052133), APE1 Asp148Glu (rs3136820), and XRCC1 Arg399Gln (rs25487), have been shown to reduce the capacity to repair oxidative damage.6 In addition, we have previously reported that individuals with hOGG1 326Cys/Cys showed significantly higher urinary 8‐OHdG concentrations than did those with 326Ser/Cys and 326Ser/Ser. As for APE1 Asp148Glu, heterozygous subjects showed significantly higher urinary 8‐OHdG concentrations than did those homozygous for Asp/Asp, suggesting that the Cys allele of hOGG1 Ser326Cys and the Glu allele of APE1 Asp148Glu might reduce the capacity to repair oxidative damage, as compared with the counterpart allele of each SNP.7 The most studied SNPs in the XRCC1 gene are Arg194Trp on exon 6, Arg280His on exon 9, and Arg399Gln on exon 10.8 A previous study reported that only the XRCC1 Arg280His variant protein is defective in its efficient localization to a damaged site in the chromosome, thereby reducing cellular BER efficiency.9 The 399Gln allele has been reported to be associated with higher mutagen sensitivity and higher levels of DNA adducts.10, 11 Several reports have shown the association of SNPs (Arg194Trp, Pro206Pro, Arg280His, Arg399Gln) in XRCC1 to diseases.12, 13, 14, 15, 16, 17, 18, 19, 20

As described above, DNA repair capacity is influenced by SNPs in BER genes, and several studies have showed the association of XRCC1 polymorphisms to diseases. Data accumulation of SNPs in XRCC1 genes is important for elucidating the interindividual differences in capacity for repairing oxidative damage and susceptibility to disease. However, to our knowledge, limited population data are available regarding SNPs in XRCC1, especially in African populations. Therefore, we have performed global ethnic comparisons of the allelic frequencies of the four SNPs in XRCC1 in 10 different populations with previous reported data.

Biological samples

Genomic DNA was extracted from blood or bloodstain samples randomly collected from the following healthy subjects: 191 Ovambos (Bantusin, Namibia), 121 Ghanaians (Accra, Ghana), 104 Xhosas (Cape Town, South Africa), 144 Mongolians (Ulaanbaatar, Mongol), 53 Tamangs (Kotyang, Nepal), 178 Tibetans (Katmandu, Nepal), 56 Tamils and 53 Sinhalese (Kandy, Sri Lanka), 100 Vietnamese (Ha Nam Province, Vietnam), and 37 Uyghurs (Urumqi of China). Informed consent was obtained from each participant. Genomic DNA was extracted from blood or bloodstain samples randomly collected from healthy subjects using the QIAamp DNA Mini Kit (QIAGEN Inc., Chatsworth, CA, USA). The study was approved by the Ethical Committees of the institutes.

Genotyping method

SNP genotyping of XRCC1 Arg194Trp(C/T) at exon 6 (rs1799782), Pro206Pro (A/G) at exon 7 (rs915927), Arg280His (G/A) at exon 9, and Arg399Gln (G/A) at exon 10 (rs25487) were analyzed by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analysis. Primers for the specific amplification of the DNA fragments encompassing a substitution site corresponding to the SNPs (Arg194Trp and Pro206Pro) were newly designed on the basis of the nucleotide sequence (Table 1 ). Primers for Arg280His and Arg399Gln were the same as in our previous study.7 Amplification was performed with a 10‐μL reaction mixture containing GoTaq® Green Master Mix (Promega, Madison, WI, USA). The PCR products were digested with each restriction enzyme (New England Biolabs, Beverly, MA, USA; Table 1 ). The digests were separated in an 8% polyacrylamide gel, and the patterns on the gels were visualized by silver staining, as described previously. Nucleotide sequences of the representative subjects were confirmed by the dideoxy chain‐terminating method with the BigDye Terminator Cycle Sequencing Kit using a 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).

Table 1.

Primer sequence, and restriction enzymes for PCR‐based genotyping of the SNPs in this study

SNPs Primer sequence Restriction enzyme
Arg194Trp Sense antisense 5’‐GCCCCGTCCCAGGTA‐3’ 5’‐AGCCCCAAGACCCTTTCACT‐3’ MspI
Pro206Pro Sense antisense 5’‐GTCCCATAGATAGGAGTGAAAG‐3’ 5’‐CCCTAGGACACAGGAGCACA‐3’ MspI
Arg399Gln Sense antisense 5’‐GGACTGTCACCGCATGCGTCGG‐3’ 5’‐GGCTGGGACCACCTGTGTT‐3’ MspI
Arg280His Sense antisense 5’‐CCAGTGGTGCTAACCTAATC‐3’ 5’‐CACTCAGCACCAGTACCACA‐3’ RsaI

Statistical analysis

A chi‐square‐analysis was performed to evaluate the Hardy–Weinberg equilibrium. Using the chi‐square test for RxC contingency tables, genotype distributions were compared between the populations.

Results and discussion

In this study, the PCR‐RFLP method was newly developed for use in genotyping Arg194Trp and Pro206Pro polymorphisms, and Arg280His and Arg399Gln were genotyped according to our previous method.7 We used a mismatched PCR amplification method for genotyping Arg194Trp and Pro206Pro. Incorporation of a deliberate mismatch close to the 3′‐terminus of a PCR primer allowed the creation of each enzyme recognition site. A DNA fragment containing a substitution site was separately amplified using a set of PCR primers and was subjected to digestion with each enzyme (Table 1 ). The validity of the genotyping results obtained by these methods was confirmed by the sequencing analysis of genomic DNA derived from several representative subjects.

The allele frequencies of the four SNPs in the XRCC1 gene of Ovambos, Ghanaians, Xhosas, Mongolian, Tamangs, Tibetans, Tamils, Sinhalese, Vietnamese, and Uyghurs, as well as those in populations studied previously28, 42,28‐42 are shown in Table 2 . The genotype distributions of these 10 populations were found to be within the Hardy–Weinberg equilibrium (data not shown). The allele frequencies differed among populations. The frequency of the minor allele corresponding to the Trp allele of XRCC1Arg194Trp was higher in Asian populations than in African and Caucasian populations: African and Caucasian populations showed lower mutant allele frequencies (<0.1). As for XRCC1Pro206Pro, genotype distributions were different among the populations: Africans showed higher minor allele frequencies than did Asian populations, except for Tamils and Sinhalese. XRCC1 Arg280His frequencies were similar among Africans and Caucasians but differed among Asian populations. Similarly, lower mutant XRCC1 Arg399Gln frequencies were observed in Africans. In this study, genotype distributions were similar among Caucasians and Asians, while those of Africans were different.

Table 2.

Genotype distribution of four XRCC1 SNPs in worldwide populations

Populations Arg194Trp (C to T) Pro206Pro (A to G) Arg280His (G to A) Arg399Gln (G to A)
N C T A G G A G A Reference
Ovambo 191 0.907 0.093 0.628 0.372 0.992 0.008 0.936 0.064 This study
Ghanaians 121 0.909 0.091 0.632 0.368 0.983 0.017 0.908 0.092 This study
Xhosans 104 0.965 0.035 0.767 0.233 0.973 0.027 0.906 0.094 This study
African American 682 0.930 0.070 0.960 0.040 0.861 0.139 Pachkowski et al. (2006)28
Mongolian 144 0.844 0.156 0.917 0.083 0.970 0.030 0.723 0.277 This study
Tamangs 53 0.736 0.264 0.896 0.104 0.922 0.078 0.736 0.264 This study
Tibetans 178 0.665 0.335 0.819 0.181 0.948 0.052 0.829 0.171 This study
Tamils 56 0.853 0.147 0.724 0.276 0.780 0.220 0.698 0.302 This study
Sinhalese 53 0.880 0.120 0.685 0.315 0.852 0.148 0.685 0.315 This study
Vietnamese 100 0.750 0.250 0.910 0.090 0.870 0.130 0.560 0.440 This study
Uygur 37 0.794 0.213 0.838 0.162 0.955 0.045 0.784 0.216 This study
Japanese 222 0.723 0.277 0.950 0.050 0.671 0.329 Weng et al. (2008)29
Taiwanese 283 0.760 0.240 0.537 0.463 Cho et al. (2003)30
Turks 93 0.900 0.100 0.670 0.330 Paridar‐Karpuzoğlu et al. (2008)31
Kazakhstan 123 0.874 0.126 0.854 0.146 0.785 0.215 Chacko et al. (2005)32
Iran 707 0.909 0.091 0.661 0.339 Mohamadynejad et al. (2008)33
Pashtuns (Afghanistan) 257 0.928 0.072 0.638 0.362 Saify et al. (2013)34
Tajiks (Afghanistan) 217 0.915 0.085 0.622 0.378 Saify et al. (2013)34
Hazaras (Afghanistan) 120 0.892 0.108 0.704 0.296 Saify et al. (2013)34
Uzbeks (Afghanistan) 62 0.855 0.145 0.766 0.234 Saify et al. (2013)34
Whites 1135 0.939 0.061 0.970 0.070 0.665 0.335 Pachkowski et al. (2006)28
Italy 324 0.910 0.090 0.483 0.517 0.628 0.372 Matullo et al. (2005)35
Spain 1096 0.939 0.061 0.927 0.073 0.621 0.379 Figueroa et al. (2007)36
Poland 124 0.912 0.088 0.609 0.391 Kowalski et al. (2009)37
France 413 0.931 0.069 0.641 0.359 Duell et al. (2000)38
Norway 377 0.952 0.048 0.960 0.040 0.624 0.376 Zienolddiny et al. (2006)39
Finland 223 0.973 0.027 0.679 0.321 Frosina et al. (2004)40
England 178 0.937 0.063 0.522 0.478 Seedhouse et al (2002)41
Belgium 110 0.923 0.077 0.651 0.349 De Ruyck et al. (2007)42

Recent studies have shown that XRCC1 Arg194Trp is a risk factor for differentiated thyroid carcinoma,13 head and neck cancer,18 and breast cancer.16 Yin et al. (2007) suggested that the XRCC1 Pro206Pro polymorphism may contribute to genetic susceptibility for lung cancer in the population of northeastern China.12 Mahjabeen et al. (2013) suggested that XRCC1 Pro206Pro may be related to susceptibility to head and neck cancers in the Pakistani population.15 Liu et al. (2013) suggested that XRCC1 Arg280His polymorphisms were risk factors for increasing bladder cancer in Asian populations.14 Salimi et al. (2014) have shown that the XRCC1 399Arg/Gln heterozygous genotype plays a protective role in systemic lupus erythematosus susceptibility.17 Zhang et al. (2014) suggested that XRCC1 Arg399Gln polymorphism may increase hepatocellular carcinoma risk, especially among Asians, but may play a protective role against hepatocellular carcinoma among Caucasians.20 In the American population, XRCC1 Arg399Gln polymorphism has been suggested to be related to breast cancer.19 Previous studies have shown lower prevalence of breast cancer in South Asian and Black women than in White women, both in the United Kingdom21, 22, 23, 24 and in the United States.25, 26, 27 In this study, XRCC1 Arg399Gln mutant frequencies were lower in Africans and Asians as compared to Caucasians. Further study is needed to clarify the relevance of XRCC1 polymorphism to the disease.

Acknowledgment

This work was partially supported by Grants‐in‐Aid from the Japan Society for the Promotion of Science (26713025 to J. Fujihara).

References

  • 1. Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004; 11: 917–922. [PubMed] [Google Scholar]
  • 2. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a metaanalysis of 38 case‐control studies. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1810–1818. [DOI] [PubMed] [Google Scholar]
  • 3. Lunec J, Holloway KA, Cooke MS, Faux S, Griffiths HR. Evans MD Urinary 8‐oxo‐2’‐deoxyguanosine: redox regulation of DNA repair in vivo? Free Radic Biol Med. 2002; 33: 875–885. [DOI] [PubMed] [Google Scholar]
  • 4. Masson M, Niedergang C, Schreiber V, Muller S, Menissier‐deMurcia J. Murci J XRCC1 is specifically associated with poly(ADP‐ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998; 18: 3563–3571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision‐repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996; 15: 6662–6670. [PMC free article] [PubMed] [Google Scholar]
  • 6. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, Kumar R, Hanova M, Pardini B, Slyskova J, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007; 28: 657–664. [DOI] [PubMed] [Google Scholar]
  • 7. Fujihara J, Soejima M, Yasuda T, Koda Y, Kunito T, Iwata H, Tanabe S, Takeshita H. Polymorphic trial in oxidative damage of arsenic exposed Vietnamese. Toxicol Appl Pharmacol. 2011; 256: 174–178. [DOI] [PubMed] [Google Scholar]
  • 8. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005; 162: 925–942. [DOI] [PubMed] [Google Scholar]
  • 9. Takanami T, Nakamura J, Kubota Y, Horiuchi S. The Arg280His polymorphism in X‐ray repair cross‐complementing gene 1 impairs DNA repair ability. Mutat Res. 2005; 582: 135–145. [DOI] [PubMed] [Google Scholar]
  • 10. Matullo G, Palli D, Peluso M, Guarrera S, Canturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, et al. XRCC1, XRCC3i XPD gene polymorphisms, smoking and 32P–DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001; 22: 1437–1445. [DOI] [PubMed] [Google Scholar]
  • 11. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst.). 2003; 2: 901–908. [DOI] [PubMed] [Google Scholar]
  • 12. Yin J, Vogel U, Ma Y, Qi R, Sun Z, Wang H. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer. 2007; 56: 153–160. [DOI] [PubMed] [Google Scholar]
  • 13. Du Y, Han LY, Li DD, Liu H, Gao YH, Sun DJ. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta‐analysis. Asian Pac J Cancer Prev. 2013; 14: 5483–5487. [DOI] [PubMed] [Google Scholar]
  • 14. Liu C, Yin Q, Li L, Jiao G, Wang M, Wang Y. XRCC1 Arg194Trp and Arg280His polymorphisms in bladder cancer susceptibility: a meta‐analysis. Crit Rev Eukaryot Gene Exp. 2013; 23: 339–354. [DOI] [PubMed] [Google Scholar]
  • 15. Mahjabeen I, Baig RM, Masood N, Sabir M, Inayat U, Malik FA, Kayani MA. Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res. 2013; 19: 183–188. [DOI] [PubMed] [Google Scholar]
  • 16. Przybylowska‐Sygut K, Stanczyk M, Kusinska R, Kordek R, Majsterek I. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer. 2013; 13: 61–68. [DOI] [PubMed] [Google Scholar]
  • 17. Salimi S, Mohammadoo‐Khorasani M, Tabatabai E, Sandoughi M, Zakeri Z, Naghavi A. XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of systemic Lupus Erythematosus in an Iranian population: a pilot study. Biomed Res Int. 2014; 492956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wu W, Liu L, Yin Z, Guan P, Li X, Zhou B. Association of X‐ray repair cross‐complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta‐analysis. PLoS One. 2014; 9: e86798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S, Li L, Chen S, Gao Y. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta‐analysis of 10846 cases and 11723 controls. PLoS One. 2014; 9: e86086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Zhang XL, Lu Y, Yang S, Peng QL, Wang J, Xie L, Deng Y, He Y, Li TJ, Qin X, et al. An updated meta‐analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2014; 15: 3273–3278. [DOI] [PubMed] [Google Scholar]
  • 21. Farooq S, Coleman MP. Breast cancer survival in South Asian women in England and Wales. J Epidemiol Commun Health. 2005; 59: 402–406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Jack RH, Davies EA, Moller H. Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer. 2009; 100: 545–550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Ali R, Barnes I, Kan SW. Beral VCancer Incidence in British Indians and British whites in Leicester, 2001–2006. Br J Cancer. 2010; 103: 143–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Downing A, West RM, Gilthorpe MS, Lawrence G, Forman D. Using routinely collected health data to investigate the association between ethnicity and breast cancer incidence and survival: what is the impact of missing data and mulitple ethnicities? Ethn Health. 2011; 16: 201–212. [DOI] [PubMed] [Google Scholar]
  • 25. Goggins WB, Wong G. Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control. 2009; 20: 635–643. [DOI] [PubMed] [Google Scholar]
  • 26. DeSantis C, Siegel R, Bandi P, Jemal A. Breast Cancer Statistics, 2011. CA Cancer J Clin. 2011; 61: 409–418. [DOI] [PubMed] [Google Scholar]
  • 27. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin. 2013; 62: 10–29. [DOI] [PubMed] [Google Scholar]
  • 28. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res. 2006; 66: 2860–2868. [DOI] [PubMed] [Google Scholar]
  • 29. Weng Z, Lu Y, Weng H, Morimoto K. Effect of the XRCC1 gene‐environment interactions on DNA damage in healthy Japanese workers. Environ Mol Mutagen. 2008; 49: 708–719. [DOI] [PubMed] [Google Scholar]
  • 30. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, Liu MY, Chen JY, Brinton LA, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1100–1104. [PubMed] [Google Scholar]
  • 31. Paridar‐Karpuzoğlu H, Doğru‐Abbasoğlu S, Hanagasi HA, Karadağ B, Gürvit H, Emre M, Uysal M. Single nucleotide polymorphisms in base‐excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci Lett. 2008; 442: 287–291. [DOI] [PubMed] [Google Scholar]
  • 32. Chacko P, Rajan B, Joseph T Mathew BS, Pillai MR. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat. 2005; 89: 15–21. [DOI] [PubMed] [Google Scholar]
  • 33. Mohamadynejad P, Saadat M. Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep. 2008; 35: 669–672. [DOI] [PubMed] [Google Scholar]
  • 34. Saify K, Saadat I, Saadat M. First survey of the two polymorphisms (Arg194Trp and Arg399Gln) in XRCC1 gene in four Afghanistan populations and comparison with worldwide data. Mol Biol Rep. 2013; 40: 5281–5284. [DOI] [PubMed] [Google Scholar]
  • 35. Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S, Karagas M, Casetta G, Rolle L, Piazza A, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case‐control study. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2569–2578. [DOI] [PubMed] [Google Scholar]
  • 36. Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardón A, Serra C, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet. 2007; 121: 233–242. [DOI] [PubMed] [Google Scholar]
  • 37. Kowalski M, Przybylowska K, Rusin P Olszewski J, Morawiec‐Sztandera A, Bielecka‐Kowalska A, Pietruszewska W, Mlynarski W, Janusz S, Majsterek I. Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res. 2009; 28: 37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC, Kelsey KT. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000; 21: 965–971. [DOI] [PubMed] [Google Scholar]
  • 39. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non‐small cell lung cancer. Carcinogenesis. 2006; 27: 560–567. [DOI] [PubMed] [Google Scholar]
  • 40. Frosina G. Commentary: DNA base excision repair defects in human pathologies. Free Radic Res. 2004; 38: 1037–1054. [DOI] [PubMed] [Google Scholar]
  • 41. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das‐Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy‐related acute myeloblastic leukemia. Blood. 2002; 100: 3761–3766. [DOI] [PubMed] [Google Scholar]
  • 42. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H. Polymorphisms in base‐excision repair and nucleotide‐excision repair genes in relation to lung cancer risk. Mutat Res. 2007; 631: 101–110. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Translational Science are provided here courtesy of Wiley

RESOURCES